Simplex Trading, LLC Silence Therapeutics PLC Transaction History
Simplex Trading, LLC
- $3.28 Billion
- Q4 2024
A detailed history of Simplex Trading, LLC transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Simplex Trading, LLC holds 51 shares of SLN stock, worth $246. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51Holding current value
$246% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SLN
# of Institutions
67Shares Held
23.6MCall Options Held
300Put Options Held
2K-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$14.7 Million3.41% of portfolio
-
Siren, L.L.C. New York, NY2.83MShares$13.7 Million0.86% of portfolio
-
Redmile Group, LLC San Francisco, CA2.4MShares$11.6 Million1.29% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY1.86MShares$8.98 Million1.01% of portfolio
-
Morgan Stanley New York, NY1.66MShares$8.05 Million0.0% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $174M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...